Lancet 369(9578):20312041
Predrag Sikirics group (School of Medicine, University of Zagreb, 1991 ) Most common experimental dose in animal studies: 10 g/kg intraperitoneally or per os, daily Standard targeted pathways: VEGFR2 angiogenesis, NO synthase , 5-HT2A serotonin receptor, dopamine D2 receptor Clinical program in Croatia halted at Phase 2 (Crohns disease) WADA Prohibited List: added in 2022 to category S0 (Non-Approved Substances) Reference sources (PubMed) Sikiric P
Le glutathion nagit jamais seul
Most treatment protocols include three phases: clear, repair, and rebuild
They help combat tiredness and support overall vitality.
Medications or Additives: If your IV therapy includes additional vitamins or medications, these can sometimes cause sensations like flushing, dizziness, or nausea